Published: Guidance, quality standards and advice
Showing 1631 to 1640 of 2422
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Multiple sclerosis | QS108 | ||
| C3 glomerulopathy in the native kidney: eculizumab | ESUOM49 | ||
| Older people: independence and mental wellbeing | NG32 | ||
| Bladder cancer | QS106 | ||
| Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears | TA369 | ||
| Bortezomib for previously untreated mantle cell lymphoma | TA370 | ||
| Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis | TA373 | ||
| Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy | TA374 | ||
| Repetitive transcranial magnetic stimulation for depression | IPG542 | ||
| Joint distraction for ankle osteoarthritis | IPG538 |